PATH
UiPath Inc. Technology - Automation Investor Relations →
UiPath Inc. (PATH) closed at $12.06 as of 2026-03-20, trading 21.3% below its 200-week moving average of $15.33. This places PATH in the extreme value zone. The stock moved further from the line this week, up from -24.6% last week. With a 14-week RSI of 28, PATH is in oversold territory.
Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.80 ratio) is neutral — neither side is clearly dominating.
Over the past 208 weeks of data, PATH has crossed below its 200-week moving average 2 times. On average, these episodes lasted 101 weeks. The average one-year return after crossing below was -20.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $6.4 billion, PATH is a mid-cap stock. The company generates a free cash flow yield of 7.5%, which is healthy. Return on equity stands at 14.4%. The stock trades at 3.1x book value.
Share count has increased 2.3% over three years, indicating dilution.
Over the past 4.1 years, a hypothetical investment of $100 in PATH would have grown to $54, compared to $152 for the S&P 500. PATH has returned -13.9% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: PATH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After PATH Crosses Below the Line?
Across 2 historical episodes, buying PATH when it crossed below its 200-week moving average produced an average return of -21.0% after 12 months (median -21.0%), compared to -8.0% for the S&P 500 over the same periods. After 24 months, the average return was +2.0% vs +19.0% for the index.
Each line shows $100 invested at the moment PATH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
PATH has crossed below its 200-week MA 2 times with an average 1-year return of +-20.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2022 | Dec 2025 | 192 | 72.4% | -20.8% | -45.6% |
| Jan 2026 | Ongoing | 10+ | 30.4% | Ongoing | -15.9% |
| Average | 101 | — | +-20.8% | — |
Frequently Asked Questions
Is PATH below its 200-week moving average?
Yes. As of 2026-03-20, UiPath Inc. (PATH) is trading 21.3% below its 200-week moving average of $15.33. The current price is $12.06.
What is PATH's 200-week moving average price?
UiPath Inc.'s 200-week moving average is $15.33 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when PATH drops below its 200-week moving average?
PATH has crossed below its 200-week moving average 2 times in our data. The average one-year return after these crossings was -20.8%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 101 weeks on average.
Is PATH a good value right now?
Here's what our data says about PATH as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 28 (oversold). Free cash flow yield is 7.5%. Return on equity is 14.4%. Price-to-book is 3.1x. This is not a buy or sell recommendation — always do your own research.
How does PATH compare to the S&P 500?
Over the past 4.1 years, $100 invested in PATH would have grown to $54, compared to $152 for the S&P 500. That's -13.9% annualized vs 10.8% for the index. PATH has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20